SCVC

Harry is the Founder of the Science Creates ecosystem, Founder & Managing Partner of SCVC, and Trustee of Science Creates Outreach. He founded his first company, Ziylo, in 2014 during his chemistry PhD. As CEO, he led Ziylo to acquisition in 2018 in a deal worth up to $800m. Three years prior, Harry built Bristol’s first Deep Tech incubator (thus founding Science Creates) after identifying the need for specialised lab space for startups in Bristol. In 2020, he founded SCVC, Science Creates’ VC arm, to back category-defining Deep Tech companies in the UK.

Harry’s work has been recognised multiple times, winning the 2023 RSC award for Chemistry World Entrepreneur of the Year and Barclays’ Icon of the Year entrepreneurship award in 2021. In 2025, Harry was awarded an MBE in the King’s 2025 New Year Honours List for his services to science.

John is a self-taught software engineer turned Deep Tech entrepreneur. As Co-Founder and CTO of Kudan Inc, he pioneered computer-vision based augmented reality in 2011, responsible for some of the most popular apps and games of the era and building the largest full-stack AR developer ecosystem. He was instrumental in pushing early deep learning into computer vision, which in 2014 led to Kudan moving deeper than AR to create Artificial Perception – an advanced form of AI used by autonomous robots and vehicles to understand and interact with the world around them. Kudan enjoyed a spectacular IPO on the Tokyo Stock Exchange in 2018, going on to exceed a $1bn market cap. John was involved in Kudan’s corporate venture capital and oversaw Kudan’s acquisition of VC-backed Artisense GmbH, a Deep Tech AI spinout from Technical University of Munich.

Cath joined SCVC at its inception, leveraging her scientific expertise to transition from academic research to a leadership role in venture capital. Since helping to found SCVC, she has developed and implemented all key investment and portfolio management processes. Cath manages SCVC’s deal and fund structures, executing over 30 deals in the last 3 years and establishing SCVC Fund 2 with a novel structure. She also directs SCVC’s contributions to Science Creates' national accelerator programmes and provides mentorship within the Science Creates ecosystem. She has a PhD in Supramolecular Chemistry from the University of Bristol and has completed a number of Post-Doctoral positions across Imperial, Southampton & Queen Mary Universities.

Laura is a Principal at SCVC, where she invests in early-stage Deep Tech companies and is Investor Director on the board of SCVC portfolio companies.

Laura has broad experience across the life sciences. She is a Biochemist with seven years research experience across industry and university settings, holding Master’s and Doctoral degrees in Biochemistry from the University of Oxford. Her research experience includes three years at TCR T-cell therapy biotech Adaptimmune.

Before joining SCVC in 2021, Laura worked at BBSRC-UKRI developing funding programmes to support the commercialisation of academic research.

Phoebe joined SCVC in 2024, following a successful internship with the firm in 2020, as the firm’s Investment Analyst, supporting SCVC’s investment process and wider operations.

She has a degree in Biochemistry and Molecular Biology and an MSc in Cancer, both from UCL. Phoebe was nominated for the UCL Dean’s Research Prize for her postgraduate research in the TRACERx lab.

Prior to joining SCVC, she worked at a specialist biotechnology consultancy firm, performing technical due diligence for early-stage investors.